Aclaris Therapeutics Inc (ACRS)
1.23
-0.01
(-0.81%)
USD |
NASDAQ |
Apr 22, 16:00
1.225
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Revenue (Quarterly): 17.57M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.57M |
| September 30, 2023 | 9.282M |
| June 30, 2023 | 1.869M |
| March 31, 2023 | 2.528M |
| December 31, 2022 | 7.753M |
| September 30, 2022 | 19.02M |
| June 30, 2022 | 1.528M |
| March 31, 2022 | 1.453M |
| December 31, 2021 | 1.501M |
| September 30, 2021 | 1.659M |
| June 30, 2021 | 1.824M |
| March 31, 2021 | 1.777M |
| December 31, 2020 | 1.58M |
| Date | Value |
|---|---|
| September 30, 2020 | 1.449M |
| June 30, 2020 | 2.046M |
| March 31, 2020 | 1.407M |
| December 31, 2019 | 1.095M |
| September 30, 2019 | 0.983M |
| June 30, 2019 | 0.886M |
| March 31, 2019 | 1.263M |
| December 31, 2018 | 1.772M |
| September 30, 2018 | 1.118M |
| June 30, 2018 | 3.676M |
| March 31, 2018 | 1.118M |
| December 31, 2017 | 0.999M |
| September 30, 2017 | 0.684M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.886M
Minimum
Jun 2019
19.02M
Maximum
Sep 2022
4.064M
Average
1.659M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.491M |
| Total Expenses (Quarterly) | 41.29M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | -31.87M |
| Gross Profit Margin (Quarterly) | 63.41% |
| Profit Margin (Quarterly) | -8.49% |
| Earnings Yield | -103.3% |
| Normalized Earnings Yield | -125.05 |